neuromuscular disease caused by qualitative or quantitative defects of dysferlin
neuromuscular disease caused by qualitative or quantitative defects of dysferlin
Explore linked clinical trials. Standard reference: MONDO:00161451 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF | Miyoshi myopathy, autosomal recessive limb-girdle muscular dystrophy type 2B, neuromuscular disease caused by qualitative or quantitative defects of dysferlin | Enrolling by invitation | Not stated | 2025-06-27 | NCT04824040 |